Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant ITGAL (Efalizumab Biosimilar) anticorps

L’anticorps Souris Chimeric anti-ITGAL (Efalizumab Biosimilar) a été validé pour BR et FACS. Il convient pour détecter ITGAL (Efalizumab Biosimilar) dans des échantillons de Humain.
N° du produit ABIN7542963

Aperçu rapide pour Recombinant ITGAL (Efalizumab Biosimilar) anticorps (ABIN7542963)

Antigène

ITGAL (Efalizumab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 1
  • 1
  • 1
  • 1
Souris

Clonalité

  • 2
  • 2
Chimeric

Conjugué

  • 4
Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application

Blocking Reagent (BR), Flow Cytometry (FACS)

Clone

Hu1124
  • Fonction

    Anti-CD11a [hu1124 (Efalizumab)], Mouse IgG2a, kappa

    Specificité

    Binds to human LFA-1.

    Attributs du produit

    Original Species of Ab: Human

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogène

    Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

    Isotype

    IgG2a kappa
  • Indications d'application

    Efalizumab binds to the LFA-1 alpha I domain blocking the ICAM-1 binding site via steric hindrance.

    Commentaires

    This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Antigène

    ITGAL (Efalizumab Biosimilar)

    Classe de substances

    Biosimilar

    Sujet

    LFA-1, integrin alpha L

    UniProt

    P20701
Vous êtes ici:
Chat with us!